Nasenspray Elac Ohne Konservierungsstoffe (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride acts as an alpha‑adrenergic agonist on the blood vessels of the nasal lining. By stimulating α1 and α2 receptors, it causes vasoconstriction, which decreases blood flow and edema in the nasal tissues, thereby opening the nasal passages and easing congestion.

The appropriate dose of Nasenspray Elac is determined by a qualified healthcare professional. Typically, the prescriber advises the number of sprays per nostril and the maximum duration of use, which should not exceed three consecutive days without medical guidance.

Safety data for Xylometazoline Hydrochloride in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their physician before using this product to weigh potential benefits against possible risks.

To order Nasenspray Elac, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Both Xylometazoline and oxymetazoline belong to the imidazoline class and act as topical alpha‑adrenergic agonists. Xylometazoline generally has a similar onset of action and duration, but individual formulations may differ in concentration, presence of preservatives, and recommended maximum usage periods. Clinical choice often depends on patient tolerance and local prescribing preferences.

Store Nasenspray Elac at room temperature, below 25 °C, in its original packaging. Keep the bottle tightly closed when not in use, protect it from moisture and direct sunlight, and avoid freezing. Do not share the spray with others to maintain sterility.

The spray is applied directly into each nostril while the head is upright. The usual instruction is to gently insert the nozzle into the nostril, press the pump to deliver the prescribed number of sprays, and then repeat in the opposite nostril if required. Avoid blowing the nose immediately after administration.

Serious risks, although rare, include severe hypertension, cardiac arrhythmias, persistent nasal irritation or ulceration, and rebound congestion (rhinitis medicamentosa) after prolonged use. If any of these symptoms occur, discontinue the spray and seek medical attention promptly.

Individuals with known hypersensitivity to Xylometazoline or any component of the formulation should avoid use. It is also contraindicated in patients with uncontrolled hypertension, severe cardiovascular disease, or those taking monoamine oxidase inhibitors unless directed by a physician. Children under six years of age should not use the spray without medical advice.